Inactive Instrument

All News BioSpecifics Technologies Corp.

Equities

BSTC

US0909311062

All News

Unlock all the news: Be the first to know and act before the market!

Fourth Amended Joint Reorganization Plan Approved for Endo International plc	Mar. 22	CI
Fourth Amended Joint Reorganization Plan Filed by Endo International plc	Mar. 18	CI
Third Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	Feb. 20	CI
Motion for Exclusivity Period Extension Approved For Endo International plc	Jan. 24	CI
Combined Hearing for Disclosure Statement and Plan Approved for Endo International plc	Jan. 12	CI
Second Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	Jan. 09	CI
First Amended Reorganization Plan and Disclosure Statement Filed by Endo International plc	Jan. 05	CI
Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	Dec. 18	CI
Third Motion for Exclusivity Period Extension Approved For Endo International plc	Nov. 15	CI
Second Motion for Exclusivity Period Extension Approved For Endo International plc	23-07-31	CI
Two Affiliate Companies Joined Endo International plc Bankruptcy	23-05-25	CI
First Motion for Exclusivity Period Extension Approved For Endo International plc	23-04-03	CI
First Motion for Exclusivity Period Extension Filed by Endo International plc	22-12-13	CI
Motion for Asset Sale Filed by Endo International plc	22-11-22	CI
Motion for Asset Sale Approved for Endo International plc	22-10-27	CI
Motion for Asset Sale Filed by Endo International plc	22-09-22	CI
Motion for De Minimis Assets Sale Filed by Endo International plc	22-09-02	CI
Motion for Joint Administration Approved for Endo International plc	22-08-17	CI
Motion for Joint Administration Filed by Endo International plc	22-08-16	CI
Endo International plc Filed for Bankruptcy	22-08-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News BioSpecifics Technologies Corp.

Equities

BSTC

US0909311062

All News

Filters